PURE Bioscience, Inc. RESTRICTED STOCK UNITS AGREEMENTRestricted Stock Units Agreement • October 28th, 2015 • Pure Bioscience, Inc. • Miscellaneous chemical products • California
THIS RESTRICTED STOCK UNITS AGREEMENT (the “Agreement”) is made and entered into as of the _____ day of ______ (the “Grant Date”), by and between PURE BIOSCIENCE, INC., a Delaware corporation, and _____________ (the “Grantee”), an executive officer of the Company. The Company has granted to the Grantee an award (the “Award”) consisting of __________ (_____) Restricted Stock Units (the “Total Number of Units”), subject to the terms and conditions of this Agreement. Each Unit represents a right to receive upon settlement one (1) share of Stock. The Award has not been granted pursuant to any compensatory, bonus, or similar plan maintained or otherwise sponsored by the Company (collectively, the “Plan”), and the shares of Stock that may become issuable upon settlement the Units shall not reduce the number of shares of Stock available for issuance under any Plan.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • October 28th, 2015 • Pure Bioscience, Inc. • Miscellaneous chemical products • New York
Transactions with Management. In the table on the following page, describe any transaction (or series of similar transactions), during the Company’s last three Fiscal Years, or any currently proposed transaction (or series of similar transactions), to which the Company or any of its subsidiaries was or is to be a party, and in which you had or anyone in your immediate family has, a material direct or indirect financial interest. Identify the person (s) involved and state the nature of your or their interest in the transaction, the amount of the transaction and the amount of your or their interest in the transaction . (Attach a supplemental page if necessary.)
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 28th, 2015 • Pure Bioscience, Inc. • Miscellaneous chemical products • Delaware
This Securities Purchase Agreement (this “Agreement”) is dated as of October 8, 2015, among Pure Bioscience, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto, each of whom shall be an Existing Investor (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
